It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

medicine

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Eisai pushes second Alzheimer's drug despite call to probe U.S. approval of first

Business / Corporate Jul 13, 2021

Eisai pushes second Alzheimer's drug despite call to probe U.S. approval of first

by Lisa Du and Grace Huang

The U.S. Food and Drug Administration’s June approval of Aduhelm caused resignations among a panel of independent experts who said the therapy was ineffective.

Pfizer outlines booster plans while regulators signal caution

World Jul 9, 2021

Pfizer outlines booster plans while regulators signal caution

Pfizer Inc. plans to request U.S. emergency authorization in August for a third booster dose of its COVID-19 vaccine.

Countries using Chinese-made vaccines and AstraZeneca increasingly eye boosters

World Jul 9, 2021

Countries using Chinese-made vaccines and AstraZeneca increasingly eye boosters

Officials are being motivated by concerns that delta and other variants appear to be breaking down defenses of vaccines not made from the supereffective messenger RNA technology.

Studies show vaccines are effective against delta variant

World / Science & Health Jul 7, 2021

Studies show vaccines are effective against delta variant

by Carl Zimmer

Jerusalem, however, announced that the effectiveness of the Pfizer-BioNTech vaccine was seen to be 64% against all COVID-19 infections — down from about 95% in May.

In Japan, anti-vaccine movement threatens to make widespread hesitancy worse

National Jun 29, 2021

In Japan, anti-vaccine movement threatens to make widespread hesitancy worse

by Tomohiro Osaki

“Zero-risk worship” in Japan has made experts concerned about the impact that a fringe community of outspoken vaccine opponents could have on the public.

Pfizer and Moderna vaccines likely produce long-lasting immunity

World Jun 28, 2021

Pfizer and Moderna vaccines likely produce long-lasting immunity

by Apoorva Mandavilli

The findings add to growing evidence that most people immunized with mRNA vaccines may not need boosters, so long as the virus and its variants do not evolve much.

Japan may reach herd immunity for COVID-19 as soon as October, study shows

National / Science & Health Jun 25, 2021

Japan may reach herd immunity for COVID-19 as soon as October, study shows

Japan may achieve herd immunity earlier than expected thanks to a recent acceleration in the country's inoculation drive, Nomura Securities Co. said in a research report.

Face masks were a booming business. Until they weren’t.

Commentary / World Jun 22, 2021

Face masks were a booming business. Until they weren’t.

by Brooke Sutherland

Face masks were the most ubiquitous visual symbol of the COVID-19 pandemic, but they’re fading from sight as more and more people get vaccinated.

A scary plan to revise the definition of death in the U.S.

Commentary / World Jun 21, 2021

A scary plan to revise the definition of death in the U.S.

by Ramesh Ponnuru

The current law’s silence about how brain death is diagnosed means that someone could be found legally dead in Nevada even if ruled alive in Kansas.

COVID-19 counting enters new era as threat shifts away from cases

World Jun 21, 2021

COVID-19 counting enters new era as threat shifts away from cases

by Todd Gillespie

With rich countries vaccinating growing proportions of their vulnerable populations, the link between infection numbers and deaths appears to be diminishing.

New Japan law lays bare hardships of children needing daily medical care

National / Science & Health Jun 20, 2021

New Japan law lays bare hardships of children needing daily medical care

by Mie Sakamoto

The number of children age under 20 who need daily medical care is estimated to total some 20,000, and getting places in education remains difficult.

Regeneron drug reduces COVID-19 patient deaths in large study

World / Science & Health Jun 16, 2021

Regeneron drug reduces COVID-19 patient deaths in large study

The results suggest there would be six fewer deaths over 28 days for every 100 patients given the company’s casirivimab and imdevimab combination of monoclonal antibodies.

« 1 … 28 29 30 … 46 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times